-
1
-
-
0035163406
-
Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
-
Despotis G.J., Avidan M.S., and Hogue Jr. C.W. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72 (2001) S1821-S1831
-
(2001)
Ann Thorac Surg
, vol.72
-
-
Despotis, G.J.1
Avidan, M.S.2
Hogue Jr., C.W.3
-
2
-
-
22244467080
-
Coagulation activation and organ dysfunction following cardiac surgery
-
Dixon B., Santamaria J., and Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 128 (2005) 229-236
-
(2005)
Chest
, vol.128
, pp. 229-236
-
-
Dixon, B.1
Santamaria, J.2
Campbell, D.3
-
3
-
-
0141609935
-
Inflammation and thrombosis
-
Esmon C.T. Inflammation and thrombosis. J Thromb Haemost 1 (2003) 1343-1348
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1343-1348
-
-
Esmon, C.T.1
-
4
-
-
7044262108
-
The impact of the inflammatory response on coagulation
-
Esmon C.T. The impact of the inflammatory response on coagulation. Thromb Res 114 (2004) 321-327
-
(2004)
Thromb Res
, vol.114
, pp. 321-327
-
-
Esmon, C.T.1
-
5
-
-
0032747159
-
Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery
-
Fransen E., Maessen J., Dentener M., et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116 (1999) 1233-1239
-
(1999)
Chest
, vol.116
, pp. 1233-1239
-
-
Fransen, E.1
Maessen, J.2
Dentener, M.3
-
6
-
-
3342939227
-
Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes
-
Spiess B.D., Royston D., Levy J.H., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44 (2004) 1143-1148
-
(2004)
Transfusion
, vol.44
, pp. 1143-1148
-
-
Spiess, B.D.1
Royston, D.2
Levy, J.H.3
-
7
-
-
0042536453
-
Novel pharmacologic approaches to reduce bleeding
-
Levy J.H. Novel pharmacologic approaches to reduce bleeding. Can J Anaesth 50 (2003) S26-S30
-
(2003)
Can J Anaesth
, vol.50
-
-
Levy, J.H.1
-
8
-
-
24944553374
-
Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation
-
Levy J.H. Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. Am J Health Syst Pharm 62 (2005) S15-S19
-
(2005)
Am J Health Syst Pharm
, vol.62
-
-
Levy, J.H.1
-
9
-
-
0037312501
-
Inflammatory response to cardiopulmonary bypass
-
Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75 (2003) S715-S720
-
(2003)
Ann Thorac Surg
, vol.75
-
-
Levy, J.H.1
Tanaka, K.A.2
-
10
-
-
2942545798
-
Bidirectional relation between inflammation and coagulation
-
Levi M., van der Poll T., and Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 109 (2004) 2698-2704
-
(2004)
Circulation
, vol.109
, pp. 2698-2704
-
-
Levi, M.1
van der Poll, T.2
Buller, H.R.3
-
11
-
-
0034949659
-
Multiple organ dysfunction syndrome: a narrative review
-
Johnson D., and Mayers I. Multiple organ dysfunction syndrome: a narrative review. Can J Anaesth 48 (2001) 502-509
-
(2001)
Can J Anaesth
, vol.48
, pp. 502-509
-
-
Johnson, D.1
Mayers, I.2
-
12
-
-
0035118319
-
Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
-
Mojcik C.F., and Levy J.H. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71 (2001) 745-754
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 745-754
-
-
Mojcik, C.F.1
Levy, J.H.2
-
13
-
-
0034053099
-
Pathophysiology of ischaemia-reperfusion injury
-
Carden D.L., and Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathol 190 (2000) 255-266
-
(2000)
J Pathol
, vol.190
, pp. 255-266
-
-
Carden, D.L.1
Granger, D.N.2
-
14
-
-
0042474500
-
The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury
-
Mackman N. The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury. Semin Vasc Med 3 (2003) 193-198
-
(2003)
Semin Vasc Med
, vol.3
, pp. 193-198
-
-
Mackman, N.1
-
15
-
-
0037804799
-
Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass
-
Chandler W.L., and Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 101 (2003) 4355-4362
-
(2003)
Blood
, vol.101
, pp. 4355-4362
-
-
Chandler, W.L.1
Velan, T.2
-
16
-
-
5644295330
-
Plasmin generation and D-dimer formation during cardiopulmonary bypass
-
Chandler W.L., and Velan T. Plasmin generation and D-dimer formation during cardiopulmonary bypass. Blood Coagul Fibrinolysis 15 (2004) 583-591
-
(2004)
Blood Coagul Fibrinolysis
, vol.15
, pp. 583-591
-
-
Chandler, W.L.1
Velan, T.2
-
17
-
-
23444439487
-
Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass
-
Chandler W.L. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 19 (2005) 459-467
-
(2005)
J Cardiothorac Vasc Anesth
, vol.19
, pp. 459-467
-
-
Chandler, W.L.1
-
18
-
-
0033584457
-
Disseminated intravascular coagulation
-
Levi M., and Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
-
(1999)
N Engl J Med
, vol.341
, pp. 586-592
-
-
Levi, M.1
Ten Cate, H.2
-
19
-
-
1142309740
-
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
-
Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 (2004) 481-497
-
(2004)
Cardiovasc Res
, vol.61
, pp. 481-497
-
-
Vinten-Johansen, J.1
-
20
-
-
0037253347
-
Participation in inflammation
-
Coughlin S.R., and Camerer E. Participation in inflammation. J Clin Invest 111 (2003) 25-27
-
(2003)
J Clin Invest
, vol.111
, pp. 25-27
-
-
Coughlin, S.R.1
Camerer, E.2
-
21
-
-
28344436780
-
Protease-activated receptors in hemostasis, thrombosis and vascular biology
-
Coughlin S.R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3 (2005) 1800-1814
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1800-1814
-
-
Coughlin, S.R.1
-
22
-
-
0033862187
-
The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1
-
Poullis M., Manning R., Laffan M., et al. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg 120 (2000) 370-378
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 370-378
-
-
Poullis, M.1
Manning, R.2
Laffan, M.3
-
23
-
-
7544236615
-
Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery
-
Day J.R., Punjabi P.P., Randi A.M., et al. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation 110 (2004) 2597-2600
-
(2004)
Circulation
, vol.110
, pp. 2597-2600
-
-
Day, J.R.1
Punjabi, P.P.2
Randi, A.M.3
-
24
-
-
30044439555
-
Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1
-
Day J.R., Taylor K.M., Lidington E.A., et al. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg 131 (2006) 21-27
-
(2006)
J Thorac Cardiovasc Surg
, vol.131
, pp. 21-27
-
-
Day, J.R.1
Taylor, K.M.2
Lidington, E.A.3
-
25
-
-
4644360059
-
Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest
-
Khan T.A., Bianchi C., Voisine P., et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 128 (2004) 602-608
-
(2004)
J Thorac Cardiovasc Surg
, vol.128
, pp. 602-608
-
-
Khan, T.A.1
Bianchi, C.2
Voisine, P.3
-
26
-
-
2442613898
-
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial
-
Verrier E.D., Shernan S.K., Taylor K.M., et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 291 (2004) 2319-2327
-
(2004)
JAMA
, vol.291
, pp. 2319-2327
-
-
Verrier, E.D.1
Shernan, S.K.2
Taylor, K.M.3
-
27
-
-
3242769906
-
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
-
Chong A.J., Shimamoto A., Hampton C.R., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128 (2004) 170-179
-
(2004)
J Thorac Cardiovasc Surg
, vol.128
, pp. 170-179
-
-
Chong, A.J.1
Shimamoto, A.2
Hampton, C.R.3
-
28
-
-
0036305603
-
The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist
-
Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
-
(2002)
Anesthesiology
, vol.97
, pp. 215-252
-
-
Laffey, J.G.1
Boylan, J.F.2
Cheng, D.C.3
-
29
-
-
0035171792
-
Pharmacologic preservation of the hemostatic system during cardiac surgery
-
Levy J.H. Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 72 (2001) S1814-S1820
-
(2001)
Ann Thorac Surg
, vol.72
-
-
Levy, J.H.1
-
30
-
-
4444380033
-
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials
-
Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
-
(2004)
J Thorac Cardiovasc Surg
, vol.128
, pp. 442-448
-
-
Sedrakyan, A.1
Treasure, T.2
Elefteriades, J.A.3
-
31
-
-
0036203002
-
Corticosteroids and cardiopulmonary bypass: a review of clinical investigations
-
Chaney M.A. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest 121 (2002) 921-931
-
(2002)
Chest
, vol.121
, pp. 921-931
-
-
Chaney, M.A.1
-
32
-
-
0033854191
-
An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation
-
Asimakopoulos G., Thompson R., Nourshargh S., et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg 120 (2000) 361-369
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 361-369
-
-
Asimakopoulos, G.1
Thompson, R.2
Nourshargh, S.3
-
33
-
-
0028792021
-
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting
-
Levy J.H., Pifarre R., Schaff H.V., et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 92 (1995) 2236-2244
-
(1995)
Circulation
, vol.92
, pp. 2236-2244
-
-
Levy, J.H.1
Pifarre, R.2
Schaff, H.V.3
-
34
-
-
24644522766
-
Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial
-
van der Linden J., Lindvall G., and Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation 112 Suppl 9 (2005) I276-I280
-
(2005)
Circulation
, vol.112
, Issue.SUPPL. 9
-
-
van der Linden, J.1
Lindvall, G.2
Sartipy, U.3
-
35
-
-
0035656032
-
The antithrombotic and antiinflammatory mechanisms of action of aprotinin
-
Landis R.C., Asimakopoulos G., Poullis M., et al. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72 (2001) 2169-2175
-
(2001)
Ann Thorac Surg
, vol.72
, pp. 2169-2175
-
-
Landis, R.C.1
Asimakopoulos, G.2
Poullis, M.3
-
36
-
-
0035171791
-
New antiinflammatory and platelet-preserving effects of aprotinin
-
Landis R.C., Haskard D.O., and Taylor K.M. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 72 (2001) S1808-S1813
-
(2001)
Ann Thorac Surg
, vol.72
-
-
Landis, R.C.1
Haskard, D.O.2
Taylor, K.M.3
-
37
-
-
29244458636
-
Transfusion immunomodulation or TRIM: what does it mean clinically?
-
Blajchman M.A. Transfusion immunomodulation or TRIM: what does it mean clinically?. Hematology 10 Suppl 1 (2005) 208-214
-
(2005)
Hematology
, vol.10
, Issue.SUPPL. 1
, pp. 208-214
-
-
Blajchman, M.A.1
-
38
-
-
15244343326
-
Transfusion-related acute lung injury
-
Silliman C.C., Ambruso D.R., and Boshkov L.K. Transfusion-related acute lung injury. Blood 105 (2005) 2266-2273
-
(2005)
Blood
, vol.105
, pp. 2266-2273
-
-
Silliman, C.C.1
Ambruso, D.R.2
Boshkov, L.K.3
-
39
-
-
0033788443
-
Transfusion-related acute lung injury
-
Popovsky M.A. Transfusion-related acute lung injury. Curr Opin Hematol 7 (2000) 402-407
-
(2000)
Curr Opin Hematol
, vol.7
, pp. 402-407
-
-
Popovsky, M.A.1
-
40
-
-
0033524140
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
-
[see comment]
-
Levi M., Cromheecke M.E., de Jonge E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. [see comment]. Lancet 354 (1999) 1940-1947
-
(1999)
Lancet
, vol.354
, pp. 1940-1947
-
-
Levi, M.1
Cromheecke, M.E.2
de Jonge, E.3
-
41
-
-
0035230145
-
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
-
CD001886
-
Henry D.A., Moxey A.J., Carless P.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) CD001886
-
(2001)
Cochrane Database Syst Rev
-
-
Henry, D.A.1
Moxey, A.J.2
Carless, P.A.3
-
42
-
-
30944448194
-
A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery
-
[quiz: A44-5]
-
Kikura M., Levy J.H., Tanaka K.A., et al. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. J Am Coll Surg 202 (2006) 216-222 [quiz: A44-5]
-
(2006)
J Am Coll Surg
, vol.202
, pp. 216-222
-
-
Kikura, M.1
Levy, J.H.2
Tanaka, K.A.3
-
43
-
-
31344467254
-
The risk associated with aprotinin in cardiac surgery
-
Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
-
(2006)
N Engl J Med
, vol.354
, pp. 353-365
-
-
Mangano, D.T.1
Tudor, I.C.2
Dietzel, C.3
-
44
-
-
33646365664
-
Aprotinin in cardiac surgery
-
[author reply: 1953-7]
-
Levy J.H., Ramsay J.G., and Guyton R.A. Aprotinin in cardiac surgery. N Engl J Med 354 (2006) 1953-1957 [author reply: 1953-7]
-
(2006)
N Engl J Med
, vol.354
, pp. 1953-1957
-
-
Levy, J.H.1
Ramsay, J.G.2
Guyton, R.A.3
-
46
-
-
3543135271
-
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
-
D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
-
(1998)
Stat Med
, vol.17
, pp. 2265-2281
-
-
D'Agostino Jr., R.B.1
-
47
-
-
0025805153
-
Channeling bias in the interpretation of drug effects
-
Petri H., and Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 10 (1991) 577-581
-
(1991)
Stat Med
, vol.10
, pp. 577-581
-
-
Petri, H.1
Urquhart, J.2
-
48
-
-
0025793562
-
Problems with using observational databases to compare treatments
-
Byar D.P. Problems with using observational databases to compare treatments. Stat Med 10 (1991) 663-666
-
(1991)
Stat Med
, vol.10
, pp. 663-666
-
-
Byar, D.P.1
-
49
-
-
9544228424
-
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators
-
Connors Jr. A.F., Speroff T., Dawson N.V., et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276 (1996) 889-897
-
(1996)
JAMA
, vol.276
, pp. 889-897
-
-
Connors Jr., A.F.1
Speroff, T.2
Dawson, N.V.3
-
50
-
-
33644680067
-
A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery
-
Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
-
(2006)
Transfusion
, vol.46
, pp. 327-338
-
-
Karkouti, K.1
Beattie, W.S.2
Dattilo, K.M.3
-
51
-
-
33644861224
-
Improving the identification of patients at risk of postoperative renal failure after cardiac surgery
-
Wijeysundera D.N., Karkouti K., Beattie W.S., et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104 (2006) 65-72
-
(2006)
Anesthesiology
, vol.104
, pp. 65-72
-
-
Wijeysundera, D.N.1
Karkouti, K.2
Beattie, W.S.3
-
52
-
-
25144454447
-
Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
-
[discussion: 1393]
-
Kincaid E.H., Ashburn D.A., Hoyle J.R., et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?. Ann Thorac Surg 80 (2005) 1388-1393 [discussion: 1393]
-
(2005)
Ann Thorac Surg
, vol.80
, pp. 1388-1393
-
-
Kincaid, E.H.1
Ashburn, D.A.2
Hoyle, J.R.3
-
53
-
-
33846511903
-
-
FDA Public Health Advisory. Available at: http://www.fda.gov/bbs/topics/news/2006/NEW01311.html. Accessed February 8, 2006.
-
-
-
-
54
-
-
0031663326
-
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations
-
discussion 541
-
Miller B.E., Tosone S.R., Tam V.K., et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 66 2 (1998) 535-540 discussion 541
-
(1998)
Ann Thorac Surg
, vol.66
, Issue.2
, pp. 535-540
-
-
Miller, B.E.1
Tosone, S.R.2
Tam, V.K.3
-
55
-
-
0442292366
-
Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials
-
discussion 642-3
-
Smith P.K., Datta S.K., Muhlbaier L.H., et al. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Ann Thorac Surg 77 2 (2004) 635-642 discussion 642-3
-
(2004)
Ann Thorac Surg
, vol.77
, Issue.2
, pp. 635-642
-
-
Smith, P.K.1
Datta, S.K.2
Muhlbaier, L.H.3
|